A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

NCT02757729 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: PAC-14028 cream 0.1%
DRUG: PAC-14028 cream 0.3%
DRUG: PAC-14028 cream 1.0%
DRUG: PAC-14028 cream vehicle

Sponsor

Amorepacific Corporation